Welcome to our dedicated page for CROWN RESV ACQUISITION I news (Ticker: CRACU), a resource for investors and traders seeking the latest updates and insights on CROWN RESV ACQUISITION I stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CROWN RESV ACQUISITION I's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CROWN RESV ACQUISITION I's position in the market.
Crown Reserve Acquisition Corp. I (Nasdaq: CRACU) priced a $150,000,000 initial public offering of 15,000,000 units at $10.00 per unit. Units begin trading on Nov 7, 2025 and the offering is expected to close on Nov 10, 2025, subject to customary conditions. Each unit contains one Class A share, one-half of a redeemable warrant and one Share Right convertible into one-fifth of a Class A share; whole warrants exercise at $11.50. An amount equal to $10.00 per unit will be deposited into a trust account. The company granted underwriters a 45-day option to purchase up to 2,250,000 additional units (15%). Management includes CEO/Chair Prashant Patel and CFO/director Eric Sherb.
FAQ
What is the current stock price of CROWN RESV ACQUISITION I (CRACU)?
